Mehmet Ali NAZLI, Emel ESMERER, Canan Kelten TALU
Istanbul Medical Journal - 2026;27(4):299-307
Introduction: To characterize the clinicopathologic features and multimodality imaging spectrum of breast involvement by hematologic malignancies and to identify imaging findings that may facilitate differentiation from primary breast carcinoma. Methods: This retrospective two-center study included consecutive patients with histopathologically confirmed breast involvement by hematologic malignancies between January 2015 and December 2025. Clinical records, pathology reports, mammography, ultrasonography, magnetic resonance imaging (MRI), and fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) examinations were reviewed. Imaging findings were analyzed with emphasis on lesion morphology, distribution pattern, laterality, nodal involvement, and systemic disease burden. Results: Seventeen patients with breast involvement by hematologic malignancies were identified among approximately 5.300 malignant breast biopsy specimens (0.3%). Mean age was 52.8 years (range, 18-86 years), and 15 patients (88.2%) were female. Histopathologic diagnoses included lymphoma (76.5%), leukemia/chronic lymphocytic leukemia (17.6%), and plasma cell neoplasm (5.9%). Solitary breast lesions were observed in 52.9% of patients, multiple lesions in 47.1%, and bilateral involvement in 41.2%. Associated nodal disease was present in 47.1% of cases. Mammographically suspicious calcifications were absent in all patients. The predominant imaging presentation consisted of oval, round, or mildly lobulated masses with circumscribed or partially circumscribed margins. Three principal sonographic patterns were identified: solitary nodular lesions, multifocal or bilateral nodular disease, and diffuse infiltrative involvement. MRI frequently demonstrated enhancing masses with diffusion restriction or extensive non-mass enhancement, whereas FDG PET/CT commonly revealed concurrent nodal and systemic disease. Conclusion: Breast involvement by hematologic malignancies demonstrates substantial imaging heterogeneity. Multifocal or bilateral disease, circumscribed nodular lesions, absence of suspicious calcifications, associated lymphadenopathy, and concurrent systemic involvement should raise suspicion for a hematologic origin and prompt appropriate clinicopathologic correlation.